ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,881.34
      -1.50%
      US Tech 100
      20,570.80
      -1.59%
      Dow Jones
      42,375.21
      -1.44%
      Brent Oil
      74.185
      0.76%
      Bitcoin
      92,068.80
      -1.55%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Monte Rosa Therapeutics Inc (GLUE)

      7. Monte Rosa Therapeutics Inc (GLUE) News

      Monte Rosa Therapeutics Inc

      Monte Rosa Therapeutics Inc (GLUE)

      NASDAQ
      6.955
      -0.105
      ( -1.49% )
      Updated: 09:34:10
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      GLUE News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 13 2024
      GLUE (-1.49%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      December 13 2024
      GLUE (-1.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 13 2024
      GLUE (-1.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 05 2024
      GLUE (-1.49%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 07 2024
      GLUE (-1.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 07 2024
      GLUE (-1.49%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 28 2024
      GLUE (-1.49%)

      GLUE Discussion

      View Posts
      Monksdream Monksdream 1 week ago
      GLUE, under $7

      👍️0
      corncakes0 corncakes0 1 month ago
      Hmm
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      $GLUE investors have been in what Cramer calls "the house of pain" for months. Many purchased this at $40,$50,$60,$70 per share. The company will be added to the long list of biotech failures once the inevitable FDA trial failure is confirmed.
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      $GLUE will soon be added to this list

      https://www.fiercebiotech.com/special-reports/2023s-top-10-clinical-trial-flops

      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      $GLUE trapped alot of "investors" earlier this week at 10+ all the way to 12.50/Share. It is cratering just as precipitously. Watch for less than 8....7.....6... in days to come.
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      $GLUE - No products. no revenues, massive losses, running out of cash. Millions of shares avaiable to short. Looking for $5/share
      👍️0
      Monksdream Monksdream 4 months ago
      GLUE under $7
      👍️0
      Monksdream Monksdream 4 months ago
      GLUE under $6
      👍️0
      Monksdream Monksdream 5 months ago
      GLUE under $5
      👍️0
      Monksdream Monksdream 6 months ago
      GLUE under $5
      👍️0

      Your Recent History

      NASDAQ
      GLUE
      Monte Rosa Therapeutics
      NASDAQ
      SURG
      SurgePays
      LSE
      30BF
      Lcr Fin.5.10%51
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads